FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2994617911> ?p ?o ?g. }

• W2994617911 endingPage "115" @default.
• W2994617911 startingPage "106" @default.
• W2994617911 abstract "Abstract Background Inflammatory arthritis including rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) are disorders at increased risk of morbidity and mortality for which a validated prognostic tool for facilitating clinical management is needed. CHA 2 DS 2 ‐VASc (congestive heart failure/hypertension/age diabetes/stroke/vascular disease/age/sex category) score was initially conceived and used to estimate thromboembolic risk in non‐valvular atrial fibrillation, and then successfully applied in community populations with sinus rhythm. We tested CHA 2 DS 2 ‐VASc‐score as a prognosticator of adverse outcomes in patients in sinus rhythm with RA/AS/PsA. Methods Between March 2014 and March 2015, 414 patients (214 RA, 75 AS, 125 PsA) in sinus rhythm without cardiac disease were consecutively analyzed and prospectively followed‐up. Primary and co‐primary end‐points were a composite of all‐cause death/all‐cause hospitalization and CV death/CV hospitalization, respectively. Results Patients were divided into LOWscore and HIGHscore groups if CHA 2 DS 2 ‐VASc was = 0/1 point or greater than 1 point, respectively. The HIGHscore group comprised 190 patients who were older with higher prevalence of CV risk factors and arthritis disease activity than 224 LOWscore patients. During a follow up of 36 months, the event rate for primary and co‐primary end‐point was 37% and 12% in the HIGHscore vs 22% and 4% in LOWscore group ( P = .001 and .002 respectively). At multivariate Cox regression analysis CHA 2 DS 2 ‐VASc‐score was related to primary end‐point (hazards ratio [HR] 1.30 [1.07‐1.59], P = .009) and co‐primary end‐point (HR 1.35 [1.01‐1.79], P = .04) independently of traditional CV risk factors analyzed individually and indexes of inflammation or disease duration. Conclusion CHA 2 DS 2 ‐VASc‐score accurately identifies in the mid‐term patients in sinus rhythm with RA/AS/PsA at different risks for CV and non‐CV mortality and hospitalization." @default.
• W2994617911 created "2019-12-26" @default.
• W2994617911 creator A5024251948 @default.
• W2994617911 creator A5026470430 @default.
• W2994617911 creator A5038627121 @default.
• W2994617911 creator A5040725162 @default.
• W2994617911 creator A5041057910 @default.
• W2994617911 creator A5045315263 @default.
• W2994617911 creator A5057958762 @default.
• W2994617911 creator A5058069385 @default.
• W2994617911 creator A5062914165 @default.
• W2994617911 creator A5071359531 @default.
• W2994617911 creator A5083250453 @default.
• W2994617911 creator A5088330359 @default.
• W2994617911 date "2019-12-19" @default.
• W2994617911 modified "2023-09-27" @default.
• W2994617911 title "Usefulness of CHA2DS2‐VASc score to predict mortality and hospitalization in patients with inflammatory arthritis" @default.
• W2994617911 cites W1116084813 @default.
• W2994617911 cites W1825458675 @default.
• W2994617911 cites W1945494843 @default.
• W2994617911 cites W1976469399 @default.
• W2994617911 cites W1987466684 @default.
• W2994617911 cites W1993663878 @default.
• W2994617911 cites W2015410646 @default.
• W2994617911 cites W2024482070 @default.
• W2994617911 cites W2043369961 @default.
• W2994617911 cites W2080514510 @default.
• W2994617911 cites W2084306320 @default.
• W2994617911 cites W2097457623 @default.
• W2994617911 cites W2115678593 @default.
• W2994617911 cites W2123664981 @default.
• W2994617911 cites W2125121941 @default.
• W2994617911 cites W2128952811 @default.
• W2994617911 cites W2133435239 @default.
• W2994617911 cites W2133435868 @default.
• W2994617911 cites W2166115469 @default.
• W2994617911 cites W2346939960 @default.
• W2994617911 cites W2547585100 @default.
• W2994617911 cites W2568337878 @default.
• W2994617911 cites W2594231908 @default.
• W2994617911 cites W2594369204 @default.
• W2994617911 cites W2626525788 @default.
• W2994617911 cites W2745542541 @default.
• W2994617911 cites W2753090874 @default.
• W2994617911 cites W2794715156 @default.
• W2994617911 cites W2808428727 @default.
• W2994617911 cites W2888369259 @default.
• W2994617911 cites W2967296969 @default.
• W2994617911 cites W3004762396 @default.
• W2994617911 doi "https://doi.org/10.1111/1756-185x.13751" @default.
• W2994617911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31854508" @default.
• W2994617911 hasPublicationYear "2019" @default.
• W2994617911 type Work @default.
• W2994617911 sameAs 2994617911 @default.
• W2994617911 citedByCount "2" @default.
• W2994617911 countsByYear W29946179112020 @default.
• W2994617911 countsByYear W29946179112021 @default.
• W2994617911 crossrefType "journal-article" @default.
• W2994617911 hasAuthorship W2994617911A5024251948 @default.
• W2994617911 hasAuthorship W2994617911A5026470430 @default.
• W2994617911 hasAuthorship W2994617911A5038627121 @default.
• W2994617911 hasAuthorship W2994617911A5040725162 @default.
• W2994617911 hasAuthorship W2994617911A5041057910 @default.
• W2994617911 hasAuthorship W2994617911A5045315263 @default.
• W2994617911 hasAuthorship W2994617911A5057958762 @default.
• W2994617911 hasAuthorship W2994617911A5058069385 @default.
• W2994617911 hasAuthorship W2994617911A5062914165 @default.
• W2994617911 hasAuthorship W2994617911A5071359531 @default.
• W2994617911 hasAuthorship W2994617911A5083250453 @default.
• W2994617911 hasAuthorship W2994617911A5088330359 @default.
• W2994617911 hasConcept C126322002 @default.
• W2994617911 hasConcept C127413603 @default.
• W2994617911 hasConcept C134018914 @default.
• W2994617911 hasConcept C164705383 @default.
• W2994617911 hasConcept C203092338 @default.
• W2994617911 hasConcept C207103383 @default.
• W2994617911 hasConcept C2775914520 @default.
• W2994617911 hasConcept C2776260265 @default.
• W2994617911 hasConcept C2777402515 @default.
• W2994617911 hasConcept C2777575956 @default.
• W2994617911 hasConcept C2778198053 @default.
• W2994617911 hasConcept C2779161974 @default.
• W2994617911 hasConcept C2780645631 @default.
• W2994617911 hasConcept C44249647 @default.
• W2994617911 hasConcept C50382708 @default.
• W2994617911 hasConcept C535046627 @default.
• W2994617911 hasConcept C555293320 @default.
• W2994617911 hasConcept C71924100 @default.
• W2994617911 hasConcept C78519656 @default.
• W2994617911 hasConceptScore W2994617911C126322002 @default.
• W2994617911 hasConceptScore W2994617911C127413603 @default.
• W2994617911 hasConceptScore W2994617911C134018914 @default.
• W2994617911 hasConceptScore W2994617911C164705383 @default.
• W2994617911 hasConceptScore W2994617911C203092338 @default.
• W2994617911 hasConceptScore W2994617911C207103383 @default.
• W2994617911 hasConceptScore W2994617911C2775914520 @default.
• W2994617911 hasConceptScore W2994617911C2776260265 @default.
• W2994617911 hasConceptScore W2994617911C2777402515 @default.

• next